Literature DB >> 9470818

Expression of syndecan-1 in human B cell chronic lymphocytic leukaemia.

A Sebestyén1, I Kovalszky, R Mihalik, M Gallai, J Bocsi, E László, S Benedek, L Sréter, L Kopper.   

Abstract

Syndecan-1 is considered an important transmembrane proteoglycan in cell-microenvironment interactions, but its exact function in normal or in transformed B cells is still unknown. In this study, RNA was isolated from peripheral cells of chronic lymphocytic leukaemia (B-CLL) and 'normal', non-leukaemic patients, as controls. Reverse PCR showed no or very low syndecan-1 mRNA expression in controls, while in 11/13 B-CLL the circulating leukaemic cells expressed syndecan-1. Similar results were obtained for interleukin-1 beta (IL-1 beta) and interleukin-6 (IL-6). Furthermore, syndecan-1 protein was detected in the majority of circulating B-CLL cells by flow cytometry and immunocytochemistry using anti-syndecan-1 MAb. Control cells were practically negative. Further study is required to understand the biological significance of syndecan-1 on B-CLL cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9470818     DOI: 10.1016/s0959-8049(97)00248-7

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  7 in total

1.  Changes of placental syndecan-1 expression in preeclampsia and HELLP syndrome.

Authors:  Szilvia Szabo; Yi Xu; Roberto Romero; Tibor Fule; Katalin Karaszi; Gaurav Bhatti; Tibor Varkonyi; Ildiko Varkonyi; Tibor Krenacs; Zhong Dong; Adi L Tarca; Tinnakorn Chaiworapongsa; Sonia S Hassan; Zoltan Papp; Ilona Kovalszky; Nandor Gabor Than
Journal:  Virchows Arch       Date:  2013-06-27       Impact factor: 4.064

2.  Plasmacellular differentiation in extranodal marginal zone B cell lymphomas of the ocular adnexa: an analysis of the neoplastic plasma cell phenotype and its prognostic significance in 136 cases.

Authors:  S E Coupland; M Hellmich; C Auw-Haedrich; W R Lee; I Anagnostopoulos; H Stein
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

3.  Syndecan-1 - A new piece in B-cell puzzle.

Authors:  L Kopper; A Sebestyén; M Gallai; I Kovalszky
Journal:  Pathol Oncol Res       Date:  1997-09       Impact factor: 3.201

4.  Soluble syndecan-1 (sCD138) as a prognostic factor independent of mutation status in patients with chronic lymphocytic leukemia.

Authors:  I Jilani; C Wei; B N Bekele; Z J Zhang; M Keating; W Wierda; A Ferrajoli; Z Estrov; H Kantarjian; S M O'Brien; F J Giles; M Albitar
Journal:  Int J Lab Hematol       Date:  2008-01-07       Impact factor: 2.877

5.  Multiset sparse partial least squares path modeling for high dimensional omics data analysis.

Authors:  Attila Csala; Aeilko H Zwinderman; Michel H Hof
Journal:  BMC Bioinformatics       Date:  2020-01-09       Impact factor: 3.169

6.  Explainable drug sensitivity prediction through cancer pathway enrichment.

Authors:  Yi-Ching Tang; Assaf Gottlieb
Journal:  Sci Rep       Date:  2021-02-04       Impact factor: 4.379

7.  Proteoglycan expression correlates with the phenotype of malignant and non-malignant EBV-positive B-cell lines.

Authors:  Alexandra Y Tsidulko; Liudmila Matskova; Lidiia A Astakhova; Ingemar Ernberg; Elvira V Grigorieva
Journal:  Oncotarget       Date:  2015-12-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.